Zunsemetinib (ATI-450; CDD-450) is a novel and potent inhibitor of p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) with the potential to be used for immuno-inflammatory disease.

纯度：≥98%

CAS：1640282-42-3